L.EO. would be just fine with me. Hey you noticed there's no bloggers coming out of the woodwork to dis zoptEC as we had in the run up to Perifosine failure.
Not bad for a .09 cent stock with cash and no debt. I'm starting to think Dodd has a game plan.
I haven't heard anything positive about the drug working at all, anyone even know, so far just a bunch of BS, nothing of substance. Long and foolish that's me
if it doesn't work and big $$$ knows this the stock should drop to .05 before Oct announcement. If it goes above .10 before Oct well then the 3rd time is the charm with AEZS phase 3 drugs.
different cancers could be the result. ERGO.L is at $179.50 share today. My guess is MRK would be interested in AEZS if this test passes so there's big $$$$$ riding on Oct announcement and the final result.
in the history of AEZS. More important than Perifosine, AEZS-130 and all others combined. Mucho important to the future of this company. Hope their bringing their A game
and your investment is golden, everyone knows that's why you still have the same negative dummies here 3 yrs later. 2 FDA Approvals and you your stock is north of $100, don't kid yourself there's only liars and buyers left in AEZS